354 Sedative Medication Wastage During Diagnostic Gastrointestinal Endoscopy: Observations from a Large District General Hospital
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.195 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von H Prill und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
Whilst most units utilize 5mg/5ml vials of Midazolam and 100mcg/2ml of Fentanyl to fulfil the maximal dosages recommended by the current guidelines, few endoscopists routinely use the full dosage with significant quantities often discarded. The aim of the present study was to examine the wastage of sedative medication during diagnostic gastrointestinal endoscopy within our unit.
Method
Consecutive patients who underwent either diagnostic OGD, colonoscopy or flexible sigmoidoscopy and received sedation at NHS Forth Valley Royal Hospital, between the 1st of May and 1st July 2025, were identified from a prospectively maintained database. The type of endoscopic procedure, the type of sedative agent administered, and the dosage used were recorded. Patients who underwent bi-directional endoscopic procedures or those who received Entonox or topical pharyngeal anaesthesia in isolation were excluded.
Results
285 gastrointestinal endoscopic procedures were performed during the study time frame. Thirty-eight percent (n=109) of patients underwent OGD, 54% (n=155) of colonoscopy and 8% (n=21) a flexible sigmoidoscopy. Midazolam was used in all 285 procedures and Fentanyl in 201 procedures. Across all endoscopic procedures, the median dose of Midazolam used was 2mg (1.5-2.5) and median Fentanyl used was 50mcg (25-50). When stratified by procedure, the median dose of Midazolam and Fentanyl used was the same for OGD and colonoscopy, 2mg (1.5-2.5) and 50mcg (25-50), respectively. Across the study period the estimated Midazolam wastage was 855mg/171 vials and Fentanyl wastage was 10, 050 mcg/ 101 vials.
Conclusions
Current trends in sedative medication usage during diagnostic gastrointestinal endoscopy have significant sustainability and potential cost implications.
Zitieren
APA
Prill, H., McGovern, J., Sergeant, L., & Hendry, P. (2026). 354 Sedative Medication Wastage During Diagnostic Gastrointestinal Endoscopy: Observations from a Large District General Hospital. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.195
Vancouver
Prill H, McGovern J, Sergeant L, Hendry P. 354 Sedative Medication Wastage During Diagnostic Gastrointestinal Endoscopy: Observations from a Large District General Hospital. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.195
BibTeX
@article{Prill2026,
author = {Prill, H and McGovern, J and Sergeant, L and Hendry, P},
title = {354 Sedative Medication Wastage During Diagnostic Gastrointestinal Endoscopy: Observations from a Large District General Hospital},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.195}
}
EUVIMED